Debt Advisory 2024 Lender Survey
Clearwater International’s Debt Advisory team surveyed 58 lenders to determine changes in the European leveraged finance market.
Read moreWe work closely with entrepreneurs and investors at the forefront of the global healthcare revolution. Our in-depth sector knowledge, combined with our technical capability, enables us to help corporates and investors capitalise on the enormous opportunities across the sector as they seek to consolidate and grow their market positions.
The ageing population, technological change, and increased demand for healthcare products and services, all create great opportunities in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. Our job is to help our clients maximise those opportunities.
Luc Bertholat, Partner, Naxicap PartnersClearwater has been very professional in leading the process involving candidates from all over the world.
The team were quickly able to identify the right partner for us and used their excellent relationship with the buyer to help negotiate a transaction that met our objectives.Dan Smart, CEO, Proclinical
With in-depth knowledge and technical capability, our healthcare team has a great track record of delivering tailored solutions.
See our teamOver 100
deals advised upon
in the last 5 years
€12.5bn
in deal value
over the last 5 years
60%
deals involving PE
in the last 5 years
Clearwater International’s Debt Advisory team surveyed 58 lenders to determine changes in the European leveraged finance market.
Read moreLooking ahead into the second half of 2023, the government is set to “clawback” over 10% of the £3.0bn NHS dental budget, which the BDA stress “does not reflect a lack of demand for dentistry, but the reality of a recruitment crisis across the frontline, leaving practices unable to fulfil their contractual commitments”.
Read moreNotable UK M&A activity across the dental market, including dental practices and dental labs.
Read more